All Stories

  1. COVID-19 Research, Public Health and Biomedical Basis
  2. Anticancer Drug Development: Evaluative Architecture
  3. COVID-19 Study, Diagnostic and Therapeutic Transition
  4. Antimetastatic Drug, Pharmacologic Challenge and Opportunity
  5. Bone Metastasis Diagnosis, Blood Biomarker Detections
  6. Anti-metastatic drug development, overview and perspectives
  7. Educational Perspectives for Nursery
  8. Drug Sensitivity Testing for Cancer Therapy, Technique Analysis and Trends
  9. Pulmonary nodules, is there any pathogenesis evidence?
  10. HIV/AIDS Curability Study, Different Approaches and Drug Combination
  11. Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
  12. Pulmonary Nodules, Surgery or Other Medication
  13. Anti-Metastatic Drug Developments, Utility of More Animal Models
  14. Several approaches for anticancer drug development progress
  15. Drug Sensitivity Testing for Cancer Therapy, Key Areas
  16. COVID-19 infection for metabolic abnormal human beings
  17. Fundamental knowledge for nurses 
  18. Nursery promotion, education and system updating
  19. Cancer Bone Metastasis, Diagnostic Insights and Drug Selection
  20. Cancer Bone Metastasis, Experimental Study
  21. Neuropsychiatric Approaches for Human Suicide Prediction and Management
  22. Osteoporosis Targeting, Possible Breakthroughs
  23. Neuropsychiatric insights for human suicide
  24. Bone Cancer and Metastasis Trials, Drug Treatment
  25. Neurobiology for human suicide
  26. Bone Disease Treatment Study, Major Pathways
  27. Pathology Study for Human Suicide
  28. Nursery activity and quality, chemistry between doctors and nurses
  29. Nursery education, narrow-range or wide-range
  30. Anticancer drug development, challenge and dilemma
  31. Life Origin on Earth, Knowledge Development
  32. HIV/AIDS treatment, therapeutic strategy break throughs
  33. Suicide Risks and Prevention, Neuropathogenic Study
  34. Medical Treatments for Chronic or Aggressive Diseases, Palliative Therapy and Nursery
  35. General information for nursery
  36. Historical analysis of suicide
  37. Drug sensitivity testing, a unique drug selection strategy
  38. Life Origin on Earth, Biochemical Approaches
  39. Herbal medicine in new era
  40. Nursery service, quality promotion
  41. Patient’s care and nursery in different diseases
  42. New HIV/AIDS Therapeutics
  43. Nursery Service in Modern Days
  44. Cancer Bioinformatics in Cancer Therapy
  45. Individualized Cancer Therapy
  46. Type 2 Diabetes Treatment and Drug Development Study
  47. Hypotheses for Life Origin on Earth, Comparison and Validation
  48. Type 2 Diabetes Study, Introduction and Perspective
  49. Anthocyanins and its biological & therapeutic characters
  50. A Critical Appraisal of Different Food Safety and Quality Management Tools to Accomplish Food Safety
  51. Pathology and treatments of obesity
  52. Obesity, Risks and Managements
  53. Keep up the pace of drug development evolution and expenditure
  54. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  55. Drug Combination in Clinical Cancer Treatments
  56. General outlook for individualized cancer therapy
  57. Ebola origin and treatment
  58. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
  59. HAART in HIV/AIDS Treatments
  60. Anticancer Drug Development, System Updating and Global Participations
  61. Human suicide study, major disciplines and treatment outcomes
  62. Anticancer drug development
  63. HIV in Human Genomes and Therapeutics
  64. HIV Biotherapy and Natural Chemotherapeutic Agents
  65. Anticancer Drug Combinations, How Far We can Go Through?
  66. Antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot
  67. Life Origin on Earth, Insights among Different Arguments
  68. Cancer metastasis treatment, a key drawbacks
  69. The suicide treatment, a new model
  70. HIV Vaccine for Prevention and Cure, A Mission Possible
  71. Zika Therapy
  72. HIV vaccine
  73. Discover Natural Chemical Drugs in Modern Medicines
  74. Mathematics in biomedical science
  75. The origin of HIV
  76. Human suicide study
  77. Pharmacogenetics of Cancer Therapy
  78. Anticancer Drug Sensitivity Testing
  79. New Perspectives of HIV/AIDS Therapy Study
  80. Antidepressant treatment study
  81. Clinical neoplasm metastasis treatments according to patient's personal conditions.
  82. Assistant cancer treatments in the clinic
  83. Drug sensitivity testing in clinical cancer treatments
  84. Anticancer drug combination in the clinic
  85. Anticancer drug pharmacogenomics in cancer chemotherapy
  86. Cost-effectiveness for personalized cancer therapy
  87. Conclusion
  88. Introduction
  89. Discussion
  90. Cancer biomarker/bioinformatics detection in clinical cancer treatments
  91. Anti-diabetic treatments
  92. Anticancer Drug Combinational Study
  93. The Origins of HIV
  94. Anti-diabetic treatments, patho-therapeutic relation
  95. Origin of Ebola, hypothesis
  96. Personalized Cancer Therapy: A Perspective
  97. Pharmacogenomics in human suicide prediction and treatments
  98. Cancer metastasis treatment study and drug developments
  99. Challenge for HIV/AIDS therapy
  100. Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
  101. Drug Combinations in Cancer Treatments
  102. New Insights into Individualized Antimetastatic Therapy
  103. Anticancer drugs on serum sialic acid level in mice bearing LLC
  104. Genetics in Neural Toxicity of Drugs
  105. Avian flu, pathogenesis and therapeutic study
  106. First Genetic Information Replication in Life Origin on Earth
  107. Origins of Life, A New Cooperative Model
  108. Cancer Metastases and Clinical Therapies
  109. Origins of Life, RNA world or alternative RNA world
  110. Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
  111. Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
  112. Antimetastatic Therapies according to Metastatic Cascade
  113. Genetics in antidepressant-induced suicide
  114. Pathology of Drug-induced mania & suicide
  115. Influenza treatment
  116. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback
  117. Individualized cancer chemotherapy
  118. High Active Antiretroviral Therapy for HIV/AIDS-Early Intervention or Later Intervention?
  119. Genomic study of antidepressant-induced suicide
  120. Aberrant sialylation in tumor cells
  121. Anti-mobility of Bisdioxopiperanes against human mammary tumors
  122. Antimetastatic activity and mechanisms of action of Bisdioxopiperazine compounds
  123. Neural toxicity of drugs
  124. Anticancer activity and mechanisms of Bisdioxopiperazines
  125. Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
  126. 14C-probimane in the mice bearing LLC
  127. Unsatisfactory design of human AIDS genome research
  128. Antidepressant in Cancer Treatment
  129. AIDS and human genome studies, from a hypothesis to systematic approaches
  130. Antidepressants in Human suicide
  131. Mathematical model in therapeutic risk prediction
  132. Fibrinogen in neoplasm metastasis
  133. Sequencing the whole genome of infected human cells obtained from diseased patients – a proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases
  134. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study
  135. Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
  136. Individualized cancer chemotheray
  137. Anti-proliferative and chromosome segregation by probimane and MST-16
  138. Effect of Anti-Cancer Drugs on the Binding of 125I-Fibrinogen to Two Leukaemia Cell Lines In Vitro
  139. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
  140. Inhibition of probimane on lipid peroxidation of rabbit and human erythrocytes
  141. Aberration of sialylation in neoplasm metastasis and possible therapeutics
  142. Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
  143. Effect of magnetized water on the mice given high doses of antineoplastic drugs
  144. Inhibition of probimane on lipoperoxidation of human red cells in vitro
  145. Enzyme dynamic study on calmodulin Ca++-Mg++-ATPase system of red blood cells inhibited by α-anordrin and probimane